Olenasufligene relduparvovec API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Olenasufligene relduparvovec is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Olenasufligene relduparvovec or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Olenasufligene relduparvovec API 2096510-84-6?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Olenasufligene relduparvovec. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Olenasufligene relduparvovec
- Synonyms:
- AAVrh10-h.SGSH , Aavrh10-hsgsh , Dna (recombinant adeno-associated virus 2 vector lys-saf302 human n-sulfoglucosamine sulfohydrolase cdna-specifying) , LYS-SAF302 , Olenasufligene relduparvovec
- Cas Number:
- 2096510-84-6
- DrugBank number:
- DB16264
- Unique Ingredient Identifier:
- 7DU50HR4GB
General Description:
Olenasufligene relduparvovec, identified by CAS number 2096510-84-6, is a notable compound with significant therapeutic applications. Olenasufligene relduparvovec is under investigation in clinical trial NCT03612869 (Study of aavrh10-h.sgsh Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)).
Categories:
Olenasufligene relduparvovec is categorized under the following therapeutic classes: Adeno-associated Viral Vector Therapies. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
